Ethics

Latest from Embase

Latest from Pubmed

List of Articles

RECORD 1
TITLE
  Cancer Research Ethics and COVID-19
AUTHOR NAMES
  Shuman A.G.;  Pentz R.D.
SOURCE
  Oncologist (2020). Date of Publication: 2020
FULL TEXT LINK
http://dx.doi.org/10.1634/theoncologist.2020-0221

RECORD 2
TITLE
  Responding to COVID-19: How to Navigate a Public Health Emergency Legally and Ethically
AUTHOR NAMES
  Gostin L.O.;  Friedman E.A.;  Wetter S.A.
SOURCE
  The Hastings Center report (2020). Date of Publication: 26 Mar 2020
ABSTRACT
  Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus SARS-CoV-2. The World Health Organization declared a public health emergency of international concern and recently classified COVID-19 as a worldwide pandemic. As of this writing, the epidemic has not yet peaked in the United States, but community transmission is widespread. President Trump declared a national emergency as fifty governors declared state emergencies. In the coming weeks, hospitals will become overrun, stretched to their capacities. When the health system becomes stretched beyond capacity, how can we ethically allocate scarce health goods and services? How can we ensure that marginalized populations can access the care they need? What ethical duties do we owe to vulnerable people separated from their families and communities? And how do we ethically and legally balance public health with civil liberties?
FULL TEXT LINK
http://dx.doi.org/10.1002/hast.1090

RECORD 3
TITLE
  Facing Covid-19 in Italy – Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line
AUTHOR NAMES
  Rosenbaum L.
SOURCE
  The New England journal of medicine (2020). Date of Publication: 18 Mar 2020
FULL TEXT LINK
http://dx.doi.org/10.1056/NEJMp2005492

RECORD 4
TITLE
  Chronology of COVID-19 cases on the Diamond Princess cruise ship and ethical considerations: a report from Japan
AUTHOR NAMES
  Nakazawa E.;  Ino H.;  Akabayashi A.
SOURCE
  Disaster medicine and public health preparedness (2020) (1-27). Date of Publication: 24 Mar 2020
ABSTRACT
  FACT: The Diamond Princess cruise ship has been anchored at the Yokohama port in Japan since February 3, 2020. A total of 691 cases of COVID-19 infection had been confirmed as of February 23. The government initially assumed that the infection was not spreading aboard and therefore indicated that any persons who either tested negative for the virus or were asymptomatic should immediately disembark. However, on February 5, the government set a 14-day health observation period because of the severity of the infection. Passengers confirmed to free from infection began disembarking on Day 15 of quarantine (February 19). FACTS TO BE EXAMINED: The effectiveness and validity of infection control, justification for the timing of inspections, and even the nature of COVID-19 itself are now all in question. ETHICAL CONSIDERATIONS: The ethical considerations related to cruise ship infection control include the reasonable justification for isolation, the psychological fragility and quality of life of the isolated passengers and crew members, the procedural justice inherent in a forced quarantine, and the optimization of control measures. PUBLIC HEALTH PREPAREDNESS: The international coordination framework and the global ramifications of such outbreaks should be reevaluated by the international community. Denying a ship’s entry based on local politics is incompatible with global justice. Events such as these require an international response and global regulations that seek to reduce disparities.
FULL TEXT LINK
http://dx.doi.org/10.1017/dmp.2020.50

RECORD 5
TITLE
  Covid-19: Control measures must be equitable and inclusive
AUTHOR NAMES
  Berger Z.D.;  Evans N.G.;  Phelan A.L.;  Silverman R.D.
SOURCE
  The BMJ (2020) 368 Article Number: m1141. Date of Publication: 20 Mar 2020
FULL TEXT LINK
http://dx.doi.org/10.1136/bmj.m1141

RECORD 6
TITLE
  Italy in a Time of Emergency and Scarce Resources: The Need for Embedding Ethical Reflection in Social and Clinical Settings
AUTHOR NAMES
  Nicoli F.;  Gasparetto A.
SOURCE
  The Journal of clinical ethics (2020) 31:1 (92-94). Date of Publication: 1 Mar 2020
ABSTRACT
  The COVID-19 virus is severely testing the Italian healthcare system, as the requests for intensive treatment are greater than the real capacity of the system to receive patients. Given this emergency situation, it follows that citizens are limited in their freedom of movement in order to limit infection, and that in hospitals a significant number of critical situations must be faced. This brief contribution aims to offer a reflection on the public and clinical role of the bioethicist: a figure able to promote dialogue between the world of medicine and the community, and to face ethical dilemmas even in emergent clinical settings.

RECORD 7
TITLE
  A Framework for Rationing Ventilators and Critical Care Beds during the COVID-19 Pandemic
AUTHOR NAMES
  White D.B.;  Lo B.
SOURCE
  JAMA – Journal of the American Medical Association (2020). Date of Publication: 2020
FULL TEXT LINK
http://dx.doi.org/10.1001/jama.2020.5046

RECORD 8
TITLE
  Fair Allocation of Scarce Medical Resources in the Time of Covid-19
AUTHOR NAMES
  Emanuel E.J.;  Persad G.;  Upshur R.;  Thome B.;  Parker M.;  Glickman A.;  Zhang C.;  Boyle C.;  Smith M.;  Phillips J.P.
SOURCE
  The New England journal of medicine (2020). Date of Publication: 23 Mar 2020
FULL TEXT LINK
http://dx.doi.org/10.1056/NEJMsb2005114

RECORD 9
TITLE
  Mitigating the impact of conference and travel cancellations on researchers’ futures
AUTHOR NAMES
  Weissgerber T.;  Bediako Y.;  de Winde C.M.;  Ebrahimi H.;  Fernández-Chiappe F.;  Ilangovan V.;  Mehta D.;  Paz Quezada C.;  Riley J.L.;  Saladi S.M.;  Sarabipour S.;  Tay A.
SOURCE
  eLife (2020) 9. Date of Publication: 27 Mar 2020
ABSTRACT
  The need to protect public health during the current COVID-19 pandemic has necessitated conference cancellations on an unprecedented scale. As the scientific community adapts to new working conditions, it is important to recognize that some of our actions may disproportionately affect early-career researchers and scientists from countries with limited research funding. We encourage all conference organizers, funders and institutions who are able to do so to consider how they can mitigate the unintended consequences of conference and travel cancellations and we provide seven recommendations for how this could be achieved. The proposed solutions may also offer long-term benefits for those who normally cannot attend conferences, and thus lead to a more equitable future for generations of researchers.
FULL TEXT LINK
http://dx.doi.org/10.7554/eLife.57032

RECORD 10
TITLE
  International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
AUTHOR NAMES
  Coles C.E.;  Aristei C.;  Bliss J.;  Boersma L.;  Brunt A.M.;  Chatterjee S.;  Hanna G.;  Jagsi R.;  Kaidar Person O.;  Kirby A.;  Mjaaland I.;  Meattini I.;  Luis A.M.;  Marta G.N.;  Offersen B.;  Poortmans P.;  Rivera S.
SOURCE
  Clinical Oncology (2020) 32:5 (279-281). Date of Publication: 1 May 2020
FULL TEXT LINK
http://dx.doi.org/10.1016/j.clon.2020.03.006

RECORD 11
TITLE
  Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
AUTHOR NAMES
  Kapata N.;  Ihekweazu C.;  Ntoumi F.;  Raji T.;  Chanda-Kapata P.;  Mwaba P.;  Mukonka V.;  Bates M.;  Tembo J.;  Corman V.;  Mfinanga S.;  Asogun D.;  Elton L.;  Arruda L.B.;  Thomason M.J.;  Mboera L.;  Yavlinsky A.;  Haider N.;  Simons D.;  Hollmann L.;  Lule S.A.;  Veas F.;  Abdel Hamid M.M.;  Dar O.;  Edwards S.;  Vairo F.;  McHugh T.D.;  Drosten C.;  Kock R.;  Ippolito G.;  Zumla A.
SOURCE
  International Journal of Infectious Diseases (2020) 93 (233-236). Date of Publication: 1 Apr 2020
FULL TEXT LINK
http://dx.doi.org/10.1016/j.ijid.2020.02.049